As a recognized leader in the contract research organization (CRO) industry for conducting complex Phase 2 trials, PharPoint Research has contributed expert services critical to the approval of many important drugs. PharPoint Research has participated in 207 Phase 2 studies in many therapeutic areas and indications, including central nervous system (CNS), dermatology, immunology, infectious disease, and oncology. Our significant Phase 2 experience encompasses 105 indications. We have provided biostatistics and data management services for dozens of these Phase 2 trials. PharPoint is a full service CRO that provides support for clinical trials at every level and phase. Our network of best in class expertise allows us to provide an accomplished service for Phase 2 studies of all types.
About the Author
Expanded Consulting Services
We recently expanded our consulting services in response to a growing need from clients. Read the full release here.